Canji Inc. preclinical data

The San Diego company reported animal results with its adenovirus-delivered gene for the p53 tumor suppressor.

As presented at the Gene Therapy of Cancer meeting in San Diego, the company's p53mut HCC rat model of human liver cancer was found to express the normal human gene after delivery by the recombinant adenovirus vector into the hepatic artery. ...